×
About 663 results

ALLMedicine™ Robotic Surgery Center

Research & Reviews  258 results

Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I ...
https://doi.org/10.1002/hed.27045
Head & Neck; Bollig CA, Morris B et. al.

Apr 3rd, 2022 - Surgery + adjuvant therapy was shown to have improved overall survival (OS) versus nonsurgical treatment in T1-T2N1-N2b human papillomavirus (HPV)-negative oropharyngeal cancer (OPC). Our objective was to compare OS in transoral robotic surgery (T...

Transoral robotic surgical excision of hypopharyngeal ectopic parathyroid adenoma causi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900033
BMJ Case Reports; James T, Lester S

Mar 6th, 2022 - Ectopic parathyroid adenomas are a rare congenital anomaly despite the complex migration parathyroid glands undergo during development. Rarer still, these can be found in the hypopharynx, become adenomas and be the cause of primary hyperparathyroi...

A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral...
https://doi.org/10.1016/j.oraloncology.2022.105798
Oral Oncology; Brody RM, Shimunov D et. al.

Mar 5th, 2022 - Increasing use of transoral robotic surgery (TORS) is likely to impact outcomes for HPV+ oropharyngeal squamous cell carcinomas (OPSCCs). We aimed to describe oncologic outcomes for a large HPV+ OPSCC cohort after TORS and develop a risk predictio...

Establishing and integrating a Trans-Oral Robotic Surgery (TORS) program into routine o...
https://doi.org/10.1017/S002221512100476X
The Journal of Laryngology and Otology; Arora A, Aina B et. al.

Feb 23rd, 2022 - Establishing and integrating a Trans-Oral Robotic Surgery (TORS) program into routine oncological management of head and neck cancer - a UK perspective.|2022|Arora A,Aina B,Georgios O,Chrysostomos T,Faulkner J,|

see more →

News  7 results

One in Four Carefully-Selected Oropharynx Resection Patients Will Likely Need Adjuvant Chemoradiotherapy
https://www.medscape.com/viewarticle/961779

Oct 29th, 2021 - NEW YORK (Reuters Health) - Among carefully selected patients with HPV-positive oropharynx squamous cell carcinoma (OPSCC) undergoing primary transoral robotic surgery (TORS), it is likely that 25% will need radiochemotherapy afterward, a single-c...

Robotic Surgery May Obviate Need for Chemotherapy in HPV-Associated Throat Cancer
https://www.staging.medscape.com/viewarticle/940648

Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...

Robotic Surgery May Obviate Need for Chemotherapy in HPV-Associated Throat Cancer
https://www.medscape.com/viewarticle/940648

Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...

Better Survival in Oropharyngeal Cancer After Robotic Surgery
https://www.medscape.com/viewarticle/936219

Aug 24th, 2020 - Transoral robotic surgery (TORS) was associated with better survival and improved surgical outcomes in comparison with nonrobotic surgery in patients with early-stage oropharyngeal cancer in a retrospective analysis of nearly 10,000 cases. The sur...

Robotic Surgery vs Radiation in Oropharyngeal Cancer
https://www.medscape.com/viewarticle/914286

Jun 12th, 2019 - CHICAGO — For patients with oropharyngeal squamous cell cancer (OPSCC), opting for radiation therapy rather than surgery may result in better swallowing outcomes, which in turn may mean a better quality of life, according to new findings. The find...

see more →